CAI
CRSP icon

Capital Advisors Inc’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$340K Sell
6,992
-300,506
-98% -$14.6M 0.01% 244
2025
Q1
$10.5M Sell
307,498
-2,772
-0.9% -$94.3K 0.21% 86
2024
Q4
$12.2M Buy
310,270
+9,681
+3% +$381K 0.24% 90
2024
Q3
$14.1M Buy
300,589
+22,583
+8% +$1.06M 0.28% 86
2024
Q2
$15M Buy
278,006
+14,020
+5% +$757K 0.31% 86
2024
Q1
$18M Buy
263,986
+8,721
+3% +$594K 0.39% 82
2023
Q4
$16M Buy
255,265
+23,340
+10% +$1.46M 0.36% 83
2023
Q3
$10.5M Buy
231,925
+15,951
+7% +$724K 0.28% 84
2023
Q2
$12.1M Buy
215,974
+50,193
+30% +$2.82M 0.31% 84
2023
Q1
$7.5M Buy
165,781
+35,867
+28% +$1.62M 0.2% 89
2022
Q4
$5.28M Buy
129,914
+1,552
+1% +$63.1K 0.15% 92
2022
Q3
$6.94M Buy
128,362
+2,477
+2% +$134K 0.22% 88
2022
Q2
$7.65M Buy
125,885
+20,903
+20% +$1.27M 0.23% 90
2022
Q1
$6.59M Buy
104,982
+2,510
+2% +$158K 0.18% 88
2021
Q4
$7.77M Buy
102,472
+31,800
+45% +$2.41M 0.21% 91
2021
Q3
$7.91M Buy
70,672
+1,191
+2% +$133K 0.24% 92
2021
Q2
$11.2M Buy
69,481
+1,724
+3% +$279K 0.34% 91
2021
Q1
$8.26M Sell
67,757
-19,911
-23% -$2.43M 0.27% 90
2020
Q4
$13.4M Sell
87,668
-49,232
-36% -$7.54M 0.48% 77
2020
Q3
$11.5M Buy
136,900
+403
+0.3% +$33.7K 0.46% 77
2020
Q2
$12.7M Buy
136,497
+2,918
+2% +$271K 0.53% 66
2020
Q1
$5.67M Buy
133,579
+6,550
+5% +$278K 0.31% 73
2019
Q4
$7.74M Buy
127,029
+10,872
+9% +$662K 0.34% 82
2019
Q3
$5.47M Hold
116,157
0.27% 84
2019
Q2
$5.47M Buy
116,157
+63,678
+121% +$3M 0.27% 84
2019
Q1
$1.88M Sell
52,479
-65,340
-55% -$2.33M 0.2% 86
2018
Q4
$3.37M Buy
117,819
+10,387
+10% +$297K 0.22% 87
2018
Q3
$4.77M Buy
107,432
+991
+0.9% +$44K 0.28% 87
2018
Q2
$6.25M Sell
106,441
-42,476
-29% -$2.5M 0.38% 79
2018
Q1
$6.81M Sell
148,917
-787
-0.5% -$36K 0.41% 80
2017
Q4
$3.52M Buy
+149,704
New +$3.52M 0.21% 94